33251120|t|Crosslink among phosphatidylinositol-3 kinase/Akt, PTEN and STAT-5A signaling pathways post liposomal galactomannan hepatocellular carcinoma therapy.
33251120|a|Liposomal drug-delivery systems (LDDs) provide a promising opportunity to precisely target organs, improve drug bioavailability and reduce systemic toxicity. On the other hand, PI3K/Akt signaling pathways control various intracellular functions including apoptosis, invasion and cell growth. Hyper activation of PI3K and Akt is detected in some types of cancer that posses defect in PTEN. Tracking the crosstalk between PI3K/Akt, PTEN and STAT 5A signaling pathways, in cancer could result in identifying new therapeutic agents. The current study, identified an over view on PI3K/Akt, PTEN and STAT-5A networks, in addition to their biological roles in hepatocellular carcinoma (HCC). In the current study galactomannan was extracted from Caesalpinia gilliesii seeds then loaded in liposomes. Liposomes were prepared employing phosphatidyl choline and different concentrations of cholesterol. HCC was then induced in Wistar albino rats followed by liposomal galactomannan (700 +- 100 nm) treatment. Liver enzymes as well as antioxidants were assessed and PI3K/Akt, PTEN and STAT-5A gene expression were investigated. The prepared vesicles revealed entrapment efficiencies ranging from 23.55 to 69.17%, and negative zeta potential values. The optimum formulation revealed spherical morphology as well as diffusion controlled in vitro release pattern. Liposomal galactomannan elucidated a significant reduction in liver enzymes and MDA as well as PI3K/Akt, PTEN and STAT 5A gene expression. A significant elevation in GST and GSH were deduced. In conclusion, Liposomal galactomannan revealed a promising candidate for HCC therapy.
33251120	46	49	Akt	Gene	24185
33251120	51	55	PTEN	Gene	50557
33251120	60	67	STAT-5A	Gene	24918
33251120	102	115	galactomannan	Chemical	MESH:C012990
33251120	116	140	hepatocellular carcinoma	Disease	MESH:D006528
33251120	298	306	toxicity	Disease	MESH:D064420
33251120	332	335	Akt	Gene	24185
33251120	471	474	Akt	Gene	24185
33251120	504	510	cancer	Disease	MESH:D009369
33251120	533	537	PTEN	Gene	50557
33251120	575	578	Akt	Gene	24185
33251120	580	584	PTEN	Gene	50557
33251120	589	596	STAT 5A	Gene	24918
33251120	620	626	cancer	Disease	MESH:D009369
33251120	730	733	Akt	Gene	24185
33251120	735	739	PTEN	Gene	50557
33251120	744	751	STAT-5A	Gene	24918
33251120	803	827	hepatocellular carcinoma	Disease	MESH:D006528
33251120	829	832	HCC	Disease	MESH:D006528
33251120	856	869	galactomannan	Chemical	MESH:C012990
33251120	889	910	Caesalpinia gilliesii	Species	191891
33251120	977	997	phosphatidyl choline	Chemical	MESH:D010713
33251120	1030	1041	cholesterol	Chemical	MESH:D002784
33251120	1043	1046	HCC	Disease	MESH:D006528
33251120	1081	1085	rats	Species	10116
33251120	1108	1121	galactomannan	Chemical	MESH:C012990
33251120	1210	1213	Akt	Gene	24185
33251120	1215	1219	PTEN	Gene	50557
33251120	1224	1231	STAT-5A	Gene	24918
33251120	1510	1523	galactomannan	Chemical	MESH:C012990
33251120	1580	1583	MDA	Chemical	MESH:D015104
33251120	1600	1603	Akt	Gene	24185
33251120	1605	1609	PTEN	Gene	50557
33251120	1614	1621	STAT 5A	Gene	24918
33251120	1674	1677	GSH	Chemical	MESH:D005978
33251120	1717	1730	galactomannan	Chemical	MESH:C012990
33251120	1766	1769	HCC	Disease	MESH:D006528
33251120	Association	MESH:C012990	24185
33251120	Association	MESH:C012990	50557
33251120	Association	24185	24918
33251120	Negative_Correlation	MESH:C012990	24918
33251120	Negative_Correlation	MESH:C012990	MESH:D006528
33251120	Association	MESH:D009369	24185
33251120	Association	MESH:D006528	50557
33251120	Association	MESH:D006528	24185
33251120	Association	MESH:D009369	24918
33251120	Positive_Correlation	MESH:C012990	MESH:D005978
33251120	Association	MESH:D006528	24918
33251120	Association	MESH:D009369	50557
33251120	Association	24185	50557
33251120	Negative_Correlation	MESH:C012990	MESH:D015104

